NCT07131306View on ClinicalTrials.gov

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2027

Primary Completion Date

August 31, 2031

Study Completion Date

August 31, 2031

Conditions
Acute-On-Chronic Liver Failure
Interventions
DRUG

ucMSC and Standard medical treatment

umbilical cord Mesenchymal stem cell1 million/kg will be given once a week for 4 week . 250 ml normal saline will be infused 30 minutes prior to ucMSCs infusion. All patients will receive the standard medical treatment.

OTHER

Standard medical treatment

Standard medical treatment

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
collaborator

Indian Council of Medical Research

OTHER_GOV

lead

Institute of Liver and Biliary Sciences, India

OTHER